Jane Street Group, LLC Athenex, Inc. Put Options Transaction History

Jane Street Group, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2021 Nov 16, 2021	SELL	$2.97 - $4.84 $65,043 - $105,996	-21,900 Reduced 28.97%	53,700 $162,000
Q2 2021 Aug 16, 2021	SELL	$3.71 - $5.13 $52,682 - $72,846	-14,200 Reduced 15.81%	75,600 $349,000
Q1 2021 May 18, 2021	BUY	$4.08 - $14.75 $308,448 - $1.12 Million	75,600 Added 532.39%	89,800 $386,000
Q3 2020 Nov 17, 2020	BUY	$10.26 - $14.55 $145,692 - $206,610	14,200 New	14,200 $172,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.